Form 4: CONMED Corp Executive Vice President & CFO, Todd W. Garner, Reports Acquisition of Restricted Stock Units

Todd W. Garner, Executive Vice President & CFO of CONMED Corp, reports the acquisition of 22,727 Restricted Stock Units (RSUs) on November 1, 2024, according to a Form 4 filing with the SEC.

Summary

• On November 1, 2024, Todd W. Garner, the Executive Vice President & CFO of CONMED Corp, acquired 22,727 Restricted Stock Units (RSUs).
• These RSUs represent a contingent right to receive one share of CONMED Corporation common stock per unit.
• The RSUs are subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and vest over two years, with 33% vesting after year 1 and 67% vesting after year 2.
• The price of the derivative security is $0.
• Following the reported transaction, Mr. Garner directly owns 22,727 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by a key executive generally indicates confidence in the company's future, but it's a routine transaction.

Positives

• The acquisition of RSUs by a high-ranking executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedule of the RSUs (33% after year 1 and 67% after year 2) suggests a long-term incentive for the executive to contribute to the company's success over the next two years.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors often monitor these filings to gauge executive sentiment and potential future performance.

Stakeholder Impact

• The acquisition of RSUs by a key executive can positively influence shareholder confidence.

Key Dates